Identification of a Plasma Proteomic Signature for Lung Cancer
NCT01752101
Carcinoma, Neoplasms
San Francisco, California, United States
View Trial DetailsNCT Number: NCT01752114
This study is intended to determine the positive predictive value (PPV) and negative predictive value (NPV) of the multiprotein classifier based on the observed study prevalence of Non-Small Cell Lung Cancer (NSCLC) in the study participants.
Looking for future studies?
Notify Me40 year and older
All sexes
Observational
University Health Network - Toronto General Hospital, Toronto, Ontario, Canada
Patients must present with previously non-diagnosed lung nodules as found on CT. There is no change to the typical standard of care that any of the investigating physicians and/or centers provide the patients enrolled in this study. The data from this study will not be used to diagnose cancer nor be used to influence treatment decisions for the study participants.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 2 years post enrollment
Incidence rate of Non-Small Cell Lung Cancer as determined by histologic or cytologic diagnosis and/or radiographically stability at 2 years post enrollment.
Integrated Diagnostics
Industry
Early Diagnosis of Pulmonary Nodules Using A Plasma Proteomic Classifier, Protocol Number 1001-12
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01752101
Carcinoma, Neoplasms
San Francisco, California, United States
View Trial DetailsNCT02158858
Blood Coagulation Disorders, Blood Platelet Disorders
Phoenix, Arizona, United States
View Trial DetailsNCT06165614
Cervical Precancer, Cervix Cancer
Kisumu, Kenya
View Trial DetailsNCT01837693
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Este, Italy
View Trial Details